Drug monitoring can be a sensitive topic for clinicians and patients alike. Learn more about how to approach the topic with patients.
Primary Care Clinician
Helping to protect your patients and your practice
Helping to ensure patient compliance
Timely insights to inform clinical decisions
Balancing clinical benefit with cost
See how inconsistent drug test results compare in your state
2019 Health Trends data now available!
An interactive state-by-state overview of patient compliance and inconsistent results
Our industry-leading toxicology experts are available to help you with results interpretation.
Give them a call today!
State monitors now available
Select the state to download an overview of an individual state’s opioid prescription guidelines
2020 Health Trends Study
Now Available! The Quest Diagnostics Health Trends™ study, published in the journal Population Health Management, compared testing rates and results from across the country before and after the onset of the pandemic.
Check this out!
Now available, Topics in Drug Testing, a new podcast series from the Quest Diagnostics drug monitoring expert
Use of so-called “full-spectrum” formulations of cannabidiol (CBD) products can cause users to test positive for THC, the component of marijuana that causes euphoria, according to an open-label study published in JAMA Psychiatry.
Rely on a trusted lab dedicated to responsible testing
With over 50 years of expertise in diagnostic testing, Quest Diagnostics has been providing insights that can lead to more informed decisions. Our drug testing solutions and approach are making a difference in cost and patient care.